All You Need to Know About Pediatrix Medical Group (MD) Rating Upgrade to Strong Buy
Pediatrix Medical Price Target Raised to $10.00/Share From $8.00 by Truist Securities
Truist Financial Maintains Pediatrix Medical(MD.US) With Hold Rating, Announces Target Price $10
Express News | Pediatrix Medical Group Inc : Truist Securities Raises Target Price to $10 From $8
Truist Adjusts Price Target on Pediatrix Medical Group to $10 From $8, Maintains Hold Rating
Insider Sale at Pediatrix Medical Group Inc (MD)
Here Is Why Bargain Hunters Would Love Fast-paced Mover Pediatrix Medical Group (MD)
Pediatrix Medical Group: Cautious Hold Rating Amidst Financial Growth and Restructuring
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bio-Techne (TECH), Pediatrix Medical Group (MD) and Arcus Biosciences (RCUS)
UBS Adjusts Pediatrix Medical Group Price Target to $10.50 From $9, Maintains Neutral Rating
Pediatrix Medical Group Analyst Ratings
Express News | Pediatrix Medical Group Inc : Mizuho Raises Target Price to $10 From $9
Pediatrix Medical Group: Strong EBITDA Amidst Strategic Shifts, Yet Uncertainties Prompt Hold Rating
J&J, Stryker Among Potential Suitors for Nevro: Wolfe
Deutsche Bank Raises Pediatrix Medical Group Price Target to $9 From $8, Maintains Hold Rating
Pediatrix Medical Group (MD) Gets a Hold From Truist Financial
Pediatrix Medical Group, Inc. (NYSE:MD) Stock Catapults 32% Though Its Price And Business Still Lag The Industry
Q2 2024 Pediatrix Medical Group Inc Earnings Call
Express News | Pediatrix Medical Group Inc : Leerink Partners Raises Target Price to $10 From $8
Express News | Pediatrix Medical Group Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Adjusted EPS Results